bluebird bio

bluebird bio develops gene therapies for severe genetic diseases using lentiviral vectors to deliver therapeutic genes. The company has approved therapies for beta-thalassemia and cerebral adrenoleukodystrophy. bluebird bio's work demonstrates both the promise and challenges of gene therapy, including manufacturing complexity and pricing.